Vit D and Peripheral Neuropathy in Taxane Naive Patients

• Status: Not yet recruiting
• Trial end date: 2024-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy of vit D supplement in cancer patients which receive taxane drugs with vit D deficiency and complaining from Peripheral neuropathy

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Vitamin D

Criteria

Inclusion Criteria:

• Any cancer patient > 18 years old receive taxane treatment

Exclusion Criteria:

• Patient which receive any line of treatment cause Peripheral neuropathy before taxane.

• Chronic disease associated with neuropathy such as diabetes mellitus, Guillain-Barre syndrome and autoimmune disease.